CRA provided expert reports and testimony in several cases involving improper diversion of diabetes test strips. CRA’s damages analyses quantified the difference in profits earned on legitimate sales of test strips in the US retail market as compared to profits earned on the diverted test strips (for example, those sold in international markets or those intended for other patient groups in the US).
Update on the Texas Business Court: July 2025
The Texas Business Court was formed in September 2024 as a specialized court that aims to provide a more efficient and predictable environment for resolving...